The nature of the information released, including any confidential product pricing, is unknown because, unlike virtually every other federal government agency, the health department does not publish its public interest certificates.
Confidential information released 47 times in six months but what and the reason remain secret
July 13, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Algorae Partners with Cadila Pharmaceuticals to launch therapies in Australia and New Zealand
October 20, 2025 - - Latest News -
Orthocell expands stake in Marine Biomedical, secures global rights to regenerative bone technology
October 20, 2025 - - Australian Biotech -
Immutep unveils dual breakthroughs at ESMO 2025, strengthening case for Efti across multiple tumour types
October 20, 2025 - - Australian Biotech -
Pharmac targets red tape to streamline access to some medicines and health consumables
October 20, 2025 - - Latest News -
Australia records worst flu season on record as vaccination rates stagnate
October 20, 2025 - - Latest News -
Merck expands commitment to first nations STEM leadership with new scholarships and partnerships
October 19, 2025 - - Latest News -
Orthocell boosts balance sheet with capital raise to drive nerve repair product growth
October 19, 2025 - - Australian Biotech